
Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories
-
HIVE Blockchain Technologies (HIVE) Announces Growth Plan to 6 EH/S, Establishes At-The-Market Equity Program
-
Wheaton Precious Metals Corp. (WPM) Renews At-The-Market Equity Program
-
SI-BONE Inc. (SIBN) Prices 3.78M Share Offering at $22/sh
-
Immunogen (IMGN) Prices 26M Share Offering at $12.50/sh
-
SI-BONE Inc. (SIBN) Launches 3.78M Share Offering
-
Taseko Mines (TGB) Announces At-the-market Offering
-
Canaccord Genuity Upgrades Emerge Commerce Ltd (ECOM:CN) to Spec. Buy
-
Intuitive Machines (LUNR) PT Lowered to $20 at Canaccord Genuity
-
Tesla (TSLA) Q1 earnings preview: Margins in focus after recent price cuts
-
Purple Biotech to Participate in Canaccord Genuity's 2023 Horizons in Oncology Virtual Conference
-
Purple Biotech to Participate in Canaccord Genuity's 2023 Horizons in Oncology Virtual Conference
-
Form 8.3 - [EMIS Group plc - 17 04 2023] - (CGWL)
-
Lithium Royalty Corp Provides Portfolio Company Updates
-
Metals Acquisition (MTAL) Announces $112 Million of PIPE Subscription Agreements Executed
-
Metals Acquisition Corp. Announces $112 Million of PIPE Subscription Agreements Executed
-
Tesla margins in focus as EV price war kicks into high gear
-
Atalaya Mining PLC Announces Q1 2023 Operations Update
-
Aether Catalyst Solutions Announces First Tranche of Non-Brokered Private Placement
-
Kodiak Closes First Tranche of $7.5 Million Private Placement
-
Arrow Announces RCE-5 Results and Operations Update
-
Volatus Aerospace Corp. Announces $3 Million Brokered Private Placement of Convertible Debenture Units
-
Olema Oncology to Participate in Canaccord Genuity 2023 Horizons in Oncology Virtual Conference
-
Olema Oncology to Participate in Canaccord Genuity 2023 Horizons in Oncology Virtual Conference
-
Arcellx to Participate at the Canaccord Genuity 2023 Horizons in Oncology Virtual Conference
-
Goldshore Announces Closing of $6.9 Million Brokered Private Placement
-
Allogene Therapeutics Announces Participation in Four Upcoming Investor Conferences
-
Allogene Therapeutics Announces Participation in Four Upcoming Investor Conferences
-
Atreca to Participate in the Canaccord Genuity Horizons in Oncology Virtual Conference
-
Atreca to Participate in the Canaccord Genuity Horizons in Oncology Virtual Conference
-
Sensei Biotherapeutics to Participate in Canaccord Genuity’s Horizons in Oncology Virtual Conference
-
Form 8.3 - [EMIS Group plc - 12 04 2023] - (CGWL)
-
Form 8.3 - [Devro plc - 12 04 2023] - (CGWL)
-
Adicet Bio to Participate in 2023 Canaccord Genuity Horizons in Oncology Virtual Conference
-
Apple (AAPL) PT Raised to $180 at Canaccord Genuity
-
Nkarta to Participate at Upcoming Investor Conferences
-
Form 8.3 - [EMIS Group plc - 11 04 2023] - (CGWL)
-
Oncolytics Biotech® to Participate in a Panel Presentation at Canaccord Genuity's Horizons in Oncology Virtual Conference
-
Canaccord remains bullish as Tesla (TSLA) continues price cuts and EPA proposes stricter regulations
-
Canaccord Genuity Reiterates Buy Rating on Tesla (TSLA) after price cuts
-
UGE Announces Q1 2023 Milestones and Business Updates
-
Form 8.3 - [Devro plc - 06 04 2023] - (CGWL)
-
Aptose to Participate in Canaccord Genuity’s 2023 Horizons in Oncology Virtual Conference
-
Hertz Lithium Inc. Completes Initial Public Offering
-
GoldHaven Appoints Bonn Smith as Incoming CEO
-
Form 8.3 - [The Fulham Shore plc - Opening Declaration - 05 04 2026] - (CGAML)
-
Form 8.3 - [Devro plc - 05 04 2023] - (CGWL)
-
AI stocks tumble after short-seller attack on C3.ai
-
Vext Science to Participate in Upcoming Investor Conferences
-
Goldshore Resources Announces Upsized $6 Million Private Placement
-
Form 8.3 - [Devro plc - 04 04 2023] - (CGWL)